These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 577471

  • 1. Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
    Briand P, Thorpe SM, Daehnfeldt JL.
    Br J Cancer; 1977 Jun; 35(6):816-21. PubMed ID: 577471
    [Abstract] [Full Text] [Related]

  • 2. Sex hormone receptors in mammary tumours of GR mice.
    Sluyser M, Evers SG, De Goeij CC.
    Nature; 1976 Sep 30; 263(5576):386-9. PubMed ID: 987544
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of mammary tumorigenesis in GR mice with 2-bromo-alpha-ergocryptine.
    Welsch CW, Goodrich-Smith M, Brown CK, Wilson M.
    Int J Cancer; 1979 Jul 15; 24(1):92-6. PubMed ID: 478693
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity of FCE 21336, a new prolactin lowering drug, on the MXT mouse mammary carcinoma.
    Zaccheo T.
    Cancer Lett; 1985 Sep 15; 28(2):237-41. PubMed ID: 4052994
    [Abstract] [Full Text] [Related]

  • 5. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
    Janik P, Briand P, Hartmann NR.
    Cancer Res; 1975 Dec 15; 35(12):3698-704. PubMed ID: 1192428
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hormone-dependent mammary tumors in strain GR/A mice. II. Preneoplastic and neoplastic properties.
    Aidells BD, Daniel CW.
    J Natl Cancer Inst; 1976 Sep 15; 57(3):519-26. PubMed ID: 978764
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Suppression of mammary tumorigenesis in C3H/He mice by ovariectomy or treatment with 2-bromo-alpha-ergocryptine: a comparison.
    Welsch CW, Lambrecht LK, Hassett CC.
    J Natl Cancer Inst; 1977 Apr 15; 58(4):1135-8. PubMed ID: 576623
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes in concanavalin A-mediated agglutination of hormone-dependent mouse mammary tumour cells during serial transplantation.
    Sluyser M, van der Valk M, van Blitterswijk WJ.
    Br J Cancer; 1980 Mar 15; 41(3):348-55. PubMed ID: 7387828
    [Abstract] [Full Text] [Related]

  • 17. Radioimmunoassay of mouse prolactin. Prolactin levels in isograft-bearing orchidectomized mice.
    Boot LM, Kwa HG, Röpcke G.
    Eur J Cancer (1965); 1973 Mar 15; 9(3):185-93. PubMed ID: 4787855
    [No Abstract] [Full Text] [Related]

  • 18. High tumour prolactin receptor content and lack of increase in serum prolactin levels as predictors of good response to endocrine therapy in rat mammary cancer.
    Di Carlo F, Muccioli G, Bellussi G, Conti G, Racca S.
    Int J Cancer; 1988 May 15; 41(5):767-70. PubMed ID: 2966772
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of biologic behavior and histology of transplanted mammary tumors in GR mice.
    Percy DH, Morris VL, MacInnes JI.
    J Natl Cancer Inst; 1982 Oct 15; 69(4):933-8. PubMed ID: 6288995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.